Pharmacovigilance in oncology focusses on monitoring medication effects to ensure patient safety. It involves collecting data on adverse drug reactions and understanding patient compliance. Regulatory compliance is vital, especially for drugs not tested on African populations. Challenges include under-reporting of adverse effects and complex reporting processes. Strategies for improvement include educating healthcare providers and engaging patients, particularly in regions like Kenya where local challenges exist.